The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the content of this announcement, and assume individual and joint responsibility for the authenticity, accuracy and completeness of the content.
Important content reminder:
●Product Type: Bank Wealth Management
●Total cash management: 650 million yuan
●Performed review procedures: The sixth meeting of the ninth board of directors held on April 21, 2022, the sixth meeting of the ninth board of supervisors, and the 2021 annual general meeting held on May 13, 2022 reviewed and approved the Proposal on Temporarily Idle Raised Funds and Own Funds for Cash Management.
1. Overview of the situation
(1) Purpose of cash management
Beijing Wandong Medical Technology Co., Ltd. (hereinafter referred to as the “Company”) in order to improve the efficiency of raised funds, rationally use part of the idle raised funds, and increase the company’s income without affecting the construction and use of raised funds projects and the safety of raised funds. , to obtain more returns for the company and shareholders.
(2) Amount of cash management
The total cash management amount this time is 650 million yuan.
(3) Source of funds and related information
The source of funds for this cash management is idle raised funds.
Approved by the China Securities Regulatory Commission “Approval for the Non-public Issuance of Shares by Beijing Wandong Medical Technology Co., Ltd.” (licensed by the China Securities Regulatory Commission)324), the company non-publicly issued 162,244,859 RMB ordinary shares (A shares) to specific objects, the issue price was 12.71 yuan per share, and the total amount of funds raised was 2,062,132,157.89 yuan. Fees and other issuance expenses totaled 15,845,933.54 yuan (excluding VAT input tax), and the actual net amount of funds raised was 2,046,286,224.35 yuan.
(IV) Basic information on cash management
China Merchants Bank’s Dianjin series is bullish on three-tiered 21-day structured deposits, and the principal of the product is invested in bank deposits and derivative financial instruments. Derivative financial instruments include but are not limited to credit, equity, commodities, foreign exchange, interest rate options and other derivative financial instruments. The linked target is gold, and the gold price referred to in this product is the market transaction price of the dollar price per ounce of gold.
Bank of Communications Yuntong Wealth Fixed-term Structured Deposit for 94 days (the linked exchange rate is bullish), the linked target under the product agreement is the central parity of the EUR/USD exchange rate, and the final performance of the product income is linked to the central parity of the EUR/USD exchange rate.
Bank of Communications Yuntong Wealth Fixed-term Structured Deposit for 94 days (the linked exchange rate is bearish), the linked target under the product agreement is the central parity of the EUR/USD exchange rate, and the final performance of the product income is linked to the central parity of the EUR/USD exchange rate.
EUR/USD is a fixed-day observation interval-type structured deposit, the pegged target is the spot exchange rate of EUR/USD, and the fixing price of the pegged target of this product is the middle price of the pegged target displayed on the Bloomberg page “BFIX” at 3:00 pm Tokyo time , take the value to five decimal places.
The bank wealth management products purchased by the company this time meet the requirements of high security, good liquidity, and guaranteed capital. There is no behavior of changing the use of raised funds in disguise, and it does not affect the construction of raised funds for investment projects and the use of raised funds.
2. Review procedures and relevant opinions
The sixth meeting of the ninth board of directors and the sixth meeting of the ninth board of supervisors will be held on April 21, 2022, and the 2021 annual general meeting will be held on May 13, 2022. Proposal for Cash Management with Self-owned Funds”, it is proposed to use idle raised funds of no more than 1 billion yuan (including 1 billion yuan) and self-owned funds of no more than 300 million yuan (including 300 million yuan) for cash management, The quota can be used on a rolling basis within 12 months from the date of deliberation and approval at the general meeting of shareholders. Cash management plans to purchase investment products (including but not limited to structural Deposits, time deposits, large-denomination certificates of deposit, etc.) shall not be used for investment behaviors for the purpose of securities investment. The company’s independent directors, the board of supervisors, and the sponsor have issued their respective opinions.
3. Investment risk analysis and risk control measures
The company will handle cash management-related business in strict accordance with the Shanghai Stock Exchange’s “Stock Listing Rules” and other relevant laws and regulations and the “Articles of Association”, and timely analyze and track the operation of cash investment products, strictly implement the company’s internal control systems, and strengthen risk control. and supervision to ensure the safety of funds.
4. Impact on the company
The company’s cash management of idle raised funds is based on the premise of effective control, which can effectively improve the efficiency of capital use and obtain certain investment benefits. More investment returns are in the interests of the company and all shareholders.
V. The amount of cash management of raised funds
As of the disclosure date of this announcement, the total cash management quota of the raised funds is 1 billion yuan, the currently used quota is 650 million yuan, and the unused quota is 350 million yuan.
Beijing Wandong Medical Technology Co., Ltd.
Board of Directors
June 24, 2022Return to Sohu, see more
Disclaimer: The opinions of this article only represent the author himself, Sohu is an information publishing platform, and Sohu only provides information storage space services.